Evaluation of antisense oligonucleotide therapy targeting Hsd17b13 in a fibrosis mice model
Yanling Ma(Bristol-Myers Squibb (Germany)), Dong Cheng(Bristol-Myers Squibb (Germany)), Ching-Hsuen Chu(Bristol-Myers Squibb (Germany)), Stephen E. Mercer(Bristol-Myers Squibb (Germany)), Stephanie Boehm(Bristol-Myers Squibb (United States)), Ivar M. McDonald(Bristol-Myers Squibb (Germany)), Bradley A. Zinker(Abbott (United States)), Julia Smith(Bristol-Myers Squibb (Germany)), Hong Cai(Institute of Microelectronics)
Cited by 14
Related Papers
An optical neural chip for implementing complex-valued neural network
|Nature Communications|2021|670
ZnO Nanosheets Abundant in Oxygen Vacancies Derived from Metal‐Organic Frameworks for ppb‐Level Gas Sensing
|Advanced Materials|2019|553
Metal‐Organic Framework Based Gas Sensors
|Advanced Science|2021|481
Carbon nanotube-enhanced electrochemical DNA biosensor for DNA hybridization detection
|Analytical and Bioanalytical Chemistry|2003|428
PTP1B antisense oligonucleotide lowers PTP1B protein, normalizes blood glucose, and improves insulin sensitivity in diabetic mice
|Proceedings of the National Academy of Sciences|2002|415